Alkem Laboratories Limited (NSE:ALKEM)
5,638.50
-9.00 (-0.16%)
Dec 4, 2025, 3:29 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 675.24 billion as of December 4, 2025. Its market cap has increased by 1.37% in one year.
Market Cap
675.24B
Enterprise Value
651.93B
Revenue
138.90B
Ranking
n/a
PE Ratio
28.60
Stock Price
5,638.50
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 675.24B, an increase of 308.74%. That is a compound annual growth rate of 15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 675.24B | 0.24% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | 349.87B | 45.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.34T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 942.29B |
| Mankind Pharma | 929.12B |
| Aurobindo Pharma | 712.47B |
| Fortis Healthcare | 693.88B |